Old Web
English
Sign In
Acemap
>
authorDetail
>
Maarten L. V. Hendrickx
Maarten L. V. Hendrickx
Katholieke Universiteit Leuven
Medicine
Fibrinolysis
Biochemistry
In vitro
Molecular biology
8
Papers
73
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Development of anti-matrix metalloproteinase-2 (MMP-2) nanobodies as potential therapeutic and diagnostic tools
2019
Nanomedicine: Nanotechnology, Biology and Medicine
Alessandro Marturano
Maarten L. V. Hendrickx
Emanuela Falcinelli
Manuela Sebastiano
Giuseppe Guglielmini
Gholamreza Hassanzadeh-Ghassabeh
Serge Muyldermans
Paul Declerck
Paolo Gresele
Show All
Source
Cite
Save
Citations (10)
In vitro and in vivo characterisation of the profibrinolytic effect of an inhibitory anti-rat TAFI nanobody
2014
Thrombosis and Haemostasis
Maarten L. V. Hendrickx
Monika Zatloukalova
Gholamreza Hassanzadeh-Ghassabeh
Serge Muyldermans
Ann Gils
Paul Declerck
Show All
Source
Cite
Save
Citations (9)
Identification of a novel, nanobody-induced, mechanism of TAFI inactivation and its in vivo application
2014
Journal of Thrombosis and Haemostasis
Maarten L. V. Hendrickx
M Zatloukalova
Gholamreza Hassanzadeh-Ghassabeh
Serge Muyldermans
Ann Gils
Paul Declerck
Show All
Source
Cite
Save
Citations (13)
TAFIa inhibiting nanobodies as profibrinolytic tools and discovery of a new TAFIa conformation
2011
Journal of Thrombosis and Haemostasis
Maarten L. V. Hendrickx
A. De Winter
Karlien Buelens
Griet Compernolle
Gholamreza Hassanzadeh-Ghassabeh
Serge Muyldermans
Ann Gils
Paul Declerck
Show All
Source
Cite
Save
Citations (21)
1